Literature DB >> 4037065

Ultrastructure of the attack of eosinophils stimulated by blood mononuclear cell products on schistosomula of Schistosoma mansoni.

J P Caulfield, H L Lenzi, P Elsas, A J Dessein.   

Abstract

Purified human eosinophils were treated with peripheral blood mononuclear cell supernatants containing eosinophil cytotoxic enhancing activity (ECEA). Schistosomula of Schistosoma mansoni which had been coated either with antibody (Ab) from the sera of infected patients or with the lectin concanavalin A (Con A) were incubated with ECEA-treated and untreated cells for 2 minutes to 12 hours and examined ultrastructurally. Killing was assayed at 18 hours. ECEA caused an increase in the killing of Ab-coated worms, but Con-A-coated worms were not killed by either ECEA-treated or untreated cells. Eosinophils began to degranulate on Ab-coated worms within 2 minutes and continued to degranulate, so that by 12 hours about half of the parasites had greater than 50% of their surface covered by discharge material. The ECEA-treated cells degranulated more than the untreated cells. There was much less discharge material on Con-A-coated worms than on Ab-coated worms. Eosinophils adhered to discharge material on the surface of both Ab- and Con-A-coated parasites. At 3 and 12 hours, lysed cells and cell fragments were also seen adhering to discharge material. In the absence of discharge material the cells adhered to residual glycocalyx or to the tegumental outer membrane. These studies suggest that eosinophils kill schistosomula by progressively degranulating onto their surface over many hours and that the increased toxicity caused by ECEA is due to an increase in discharge.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4037065      PMCID: PMC1887990     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni.

Authors:  M A Vadas; J R David; A Butterworth; N T Pisani; T A Siongok
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

2.  Schistosoma mansoni: defined system for stepwise transformation of cercaria to schistosomule in vitro.

Authors:  F J Ramalho-Pinto; G Gazzinelli; R E Howells; T A Mota-Santos; E A Figueiredo; J Pellegrino
Journal:  Exp Parasitol       Date:  1974-12       Impact factor: 2.011

3.  Interactions between human eosinophils and schistosomula of Schistosoma mansoni. I. Stable and irreversible antibody-dependent adherence.

Authors:  M A Vadas; A E Butterworth; B Sherry; A Dessein; M Hogan; D Bout; J R David
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

4.  Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein.

Authors:  A E Butterworth; D L Wassom; G J Gleich; D A Loegering; J R David
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

5.  Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides.

Authors:  A R Anwar; J R McKean; S R Smithers; A B Kay
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

6.  Demonstration of eosinophil degranulation on the surface of opsonized schistosomules by phase-contrast cinemicrography.

Authors:  P Densen; A A Mahmoud; J Sullivan; K S Warren; G L Mandell
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

7.  Rat mast cell-eosinophil interaction in antibody-dependent eosinophil cytotoxicity to Schistosoma mansoni schistosomula.

Authors:  M Capron; J Rousseaux; C Mazingue; H Bazin; A Capron
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

8.  Definition and collection in quantity of schistosomules of Schistosoma mansoni.

Authors:  M A Stirewalt; D R Minnick; W A Fregeau
Journal:  Trans R Soc Trop Med Hyg       Date:  1966       Impact factor: 2.184

9.  The mechansim of antibody-dependent, eosinophil-mediated damage to schistosomula of Schistosoma mansoni in vitro: a study by phase-contrast and electron microscopy.

Authors:  A M Glauert; A E Butterworth; R F Sturrock; V Houba
Journal:  J Cell Sci       Date:  1978-12       Impact factor: 5.285

10.  Interactions between human eosinophils and schistosomula of Schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence.

Authors:  A E Butterworth; M A Vadas; D L Wassom; A Dessein; M Hogan; B Sherry; G J Gleich; J R David
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

View more
  7 in total

1.  A serum factor that suppresses the cytotoxic function of cytokine-stimulated human eosinophils.

Authors:  D S Silberstein; M S Minkoff; A A Creasey; J R David
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

2.  Freshly isolated and cultured human monocytes obtained by plasmapheresis kill schistosomula of Schistosoma mansoni.

Authors:  M Lehn; C P Chiang; H G Remold; J R Swafford; J P Caulfield
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

3.  Autoreactive eosinophils associated with spontaneous autocytotoxicity in bronchial asthma.

Authors:  W K Podleski
Journal:  Agents Actions       Date:  1988-06

4.  Human monocyte-derived macrophages are lysed by schistosomula of Schistosoma mansoni and fail to kill the parasite after activation with interferon gamma.

Authors:  H G Remold; A Mednis; A Hein; J P Caulfield
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

Review 5.  Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules.

Authors:  Maria João Gouveia; Paul J Brindley; Fátima Gärtner; José M Correia da Costa; Nuno Vale
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-05

6.  A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice.

Authors:  Dilhan J Perera; Adam S Hassan; Sunny S Liu; Seyyed Mehdy Elahi; Christine Gadoury; Risini D Weeratna; Rénald Gilbert; Momar Ndao
Journal:  EBioMedicine       Date:  2022-04-30       Impact factor: 11.205

7.  Schistosomula of Schistosoma mansoni use lysophosphatidylcholine to lyse adherent human red blood cells and immobilize red cell membrane components.

Authors:  D E Golan; C S Brown; C M Cianci; S T Furlong; J P Caulfield
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.